Targovax to Present at Jefferies 2018 Global Healthcare Conference
Oslo, Norway, 4 June 2018: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that CMO Magnus Jäderberg will present a company overview at the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2018 at 16:00 EDT in New York, NY. Presentation slides will be available following the event at www.targovax.com/Investors. For information about the conference, visit https://www.jefferies.com/OurFirm/Conferences/325/382For further information, please contact: